Dermatology focuses on the health of the skin, hair, and nails. Learn about the diagnosis and treatment of acne, eczema, skin cancer, and cosmetic procedures.
Send us all your questions or requests, and our expert team will assist you.
The diagnosis and evaluation of contact dermatitis is a critical first step toward effective treatment and long‑term skin health. Whether you are a patient traveling from abroad or a referring physician seeking a clear pathway for care, this page outlines the complete process used by Liv Hospital’s dermatology team. More than 20 % of dermatologic visits worldwide involve allergic or irritant reactions, making accurate assessment essential for preventing chronic disease and improving quality of life.
Our specialists combine detailed medical history, visual examination, and state‑of‑the‑art testing to pinpoint the exact cause of a skin reaction. From simple patch testing to advanced imaging, each component of the diagnosis and evaluation protocol is designed to be thorough, patient‑centered, and aligned with international standards. Below you will find a step‑by‑step breakdown of what to expect during your visit, the tools we use, and how the results guide a personalized management plan.
International patients benefit from Liv Hospital’s 360‑degree support, including interpreter services, coordinated appointments, and assistance with travel logistics, ensuring that the diagnostic journey is smooth and stress‑free.
Contact dermatitis is broadly classified into two categories: allergic contact dermatitis (ACD) and irritant contact dermatitis (ICD). Recognizing the distinction is essential for accurate diagnosis and evaluation because each type follows a different pathophysiology and therefore requires distinct management strategies.
ACD is an immune‑mediated response that occurs after skin contact with a sensitizing substance. Common allergens include nickel, fragrance compounds, preservatives, and certain plants such as poison ivy.
ICD results from direct chemical or physical damage to the skin barrier. Frequent culprits are soaps, detergents, solvents, and prolonged exposure to water.
Feature | Allergic (ACD) | Irritant (ICD)
|
|---|---|---|
Onset after exposure | 12–48 hours (delayed) | Immediate to a few hours |
Distribution | Localized to contact area | Often broader, may affect adjacent skin |
Re‑exposure response | Worsening, possible systemic symptoms | Similar severity each exposure |
Understanding these differences guides the subsequent steps of the diagnosis and evaluation process, ensuring that testing is appropriately targeted.
A meticulous patient history is the cornerstone of the diagnosis and evaluation of contact dermatitis. Our dermatologists ask a series of structured questions to capture exposure details, symptom chronology, and personal or occupational risk factors.
During the visual examination, clinicians assess the morphology of lesions—whether they are erythematous, vesicular, papular, or lichenified. Photographs may be taken for baseline documentation and future comparison.
In addition to the standard interview, Liv Hospital offers multilingual interpreter support, allowing non‑English speaking patients to convey nuanced exposure information without language barriers. This comprehensive approach reduces diagnostic errors and accelerates the path to effective therapy.
When history and physical examination suggest contact dermatitis, targeted testing confirms the specific trigger. The most widely used method is patch testing, complemented by other laboratory assessments when indicated.
Patch testing involves applying small amounts of standardized allergens to the back using adhesive chambers. The patches remain in place for 48 hours, after which the skin is evaluated at 48 hours and again at 72–96 hours for delayed reactions.
In selected cases, skin biopsy, serum IgE measurement, or cytokine profiling may be employed In selected cases, skin biopsy, serum IgE measurement, or cytokine profiling may be employed to differentiate allergic from irritant mechanisms or to rule out other dermatoses.
Test | Purpose | Typical Indication
|
|---|---|---|
Patch Test | Identify specific allergens | Unclear trigger after history |
Skin Biopsy | Exclude psoriasis, eczema, infection | Atypical lesions or chronic course |
Serum IgE | Assess atopic predisposition | Concurrent allergic rhinitis/asthma |
All tests are performed in Liv Hospital’s accredited dermatology laboratory, ensuring reliability and rapid turnaround—critical for an efficient diagnosis and evaluation workflow.
While visual inspection remains primary, certain cases benefit from imaging technologies that reveal subclinical inflammation or help differentiate contact dermatitis from other dermatoses.
High‑resolution dermatoscopes allow clinicians to examine vascular patterns, scaling, and pigment distribution. This non‑invasive tool is especially useful for distinguishing eczematous lesions from early psoriasis.
Ultrasound at frequencies above 20 MHz can measure epidermal thickness and detect edema in the dermis, providing objective data for disease severity.
RCM offers cellular‑level imaging without a biopsy, useful for patients who cannot tolerate invasive procedures.
These advanced modalities are integrated into the diagnosis and evaluation protocol when standard testing does not yield a clear answer, ensuring that every patient receives a precise and personalized diagnosis.
After completing history, examination, and testing, the dermatology team synthesizes the data to create a tailored management plan. The plan addresses both immediate symptom relief and long‑term prevention.
Liv Hospital provides written care plans in the patient’s native language, reinforced by interpreter‑assisted counseling sessions. Follow‑up appointments are scheduled based on severity, with the option of tele‑medicine check‑ins for international travelers.
Effective monitoring ensures that the chosen interventions remain appropriate and that any new sensitizations are detected early. The follow‑up schedule is customized according to the initial severity and patient preferences.
Clinicians use validated scoring systems such as the Contact Dermatitis Severity Index (CDSI) to quantify improvement. Photographic documentation at each visit provides visual confirmation of progress.
Visit | Focus | Tools Used
|
|---|---|---|
2 weeks | Assess acute response | Clinical exam, patient diary |
6–8 weeks | Adjust therapy if needed | CDSI scoring, photos |
6 months | Long‑term prevention | Patch test re‑evaluation if new exposures |
Continuous communication with Liv Hospital’s international patient services team ensures that any travel‑related challenges—such as medication access or follow‑up logistics—are proactively managed, preserving the integrity of the diagnosis and evaluation continuum.
Liv Hospital combines JCI accreditation, cutting‑edge dermatology expertise, and a dedicated international patient program. Our multidisciplinary team coordinates every step of the diagnosis and evaluation pathway, from initial consultation to post‑treatment monitoring, while providing language support, visa assistance, and comfortable accommodation options. Choosing Liv Hospital means receiving world‑class care in a culturally sensitive environment, tailored to the needs of patients traveling from any corner of the globe.
Ready to take control of your skin health? Contact Liv Hospital today to schedule your comprehensive contact dermatitis assessment. Our international patient coordinators are standing by to arrange appointments, travel logistics, and personalized care plans—so you can focus on healing.
Liv Hospital Ulus
Asst. Prof. MD. Ayşe Deniz Akkaya
Dermatology
Liv Hospital Ulus
Asst. Prof. MD. Nazlı Caf
Dermatology
Liv Hospital Ulus
Prof. MD. İlteriş Oğuz
Dermatology
Liv Hospital Ulus
Spec. MD. Ömer Gezdur
Dermatology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Ece Altun
Dermatology
Liv Hospital Vadistanbul
Prof. MD. Sevilay Oğuz Kılıç
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Marziyeh Javadpour
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Meryem Ayşit
Dermatology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Nadir Göksügür
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Esengül Kaya
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Vedat Ertunç
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Özlem İpek
Dermatology
Liv Hospital Topkapı
Spec. MD. Betül Kızılkan
Dermatology
Liv Hospital Topkapı
Spec. MD. Gizem Gökçedağ Ünsal
Dermatology
Liv Hospital Ankara
Asst. Prof. MD. Caner Demircan
Dermatology
Liv Hospital Ankara
Spec. MD. Aylin Gözübüyükoğulları
Dermatology
Liv Hospital Ankara
Spec. MD. Elçin Akdaş
Dermatology
Liv Hospital Ankara
Spec. MD. Vahid Ahmadi
Dermatology
Liv Hospital Gaziantep
Spec. MD. Hatice Kübra Çakı
Dermatology
Liv Hospital Samsun
Asst. Prof. MD. Gül Şekerlisoy Tatar
Dermatology
Liv Hospital Samsun
Spec. MD. Ayşe İdil Baş
Dermatology
Liv Bona Dea Hospital Bakü
Spec. MD. İRFAN QEHREMANOV
Dermatology
Asst. Prof. MD. A. Deniz Akkaya
Dermatology
MD. Gül Şekerlisoy Tatar
Dermatology
Send us all your questions or requests, and our expert team will assist you.
Allergic contact dermatitis occurs when the immune system becomes sensitized to a substance such as nickel, fragrances, or certain plants. Symptoms typically appear 12–48 hours after exposure and are confined to the area of contact, often worsening with re‑exposure and sometimes causing systemic signs. Irritant contact dermatitis, on the other hand, is caused by direct irritation from soaps, detergents, solvents, or prolonged water exposure. It can appear immediately or within a few hours, may affect a broader area beyond the point of contact, and usually shows a consistent severity with each exposure. Recognizing these patterns helps clinicians choose the appropriate testing, such as patch testing for ACD and avoidance strategies for ICD.
During a patch test, adhesive chambers containing a series of common allergens (e.g., the European baseline series) are placed on the patient’s upper back. The patches remain in place for 48 hours, after which the clinician removes them and reads the results. A second reading at 72–96 hours captures delayed hypersensitivity reactions. Positive reactions appear as erythema, papules, or vesicles, indicating a specific sensitizer. The International Contact Dermatitis Research Group (ICDRG) criteria guide interpretation. If the initial series is inconclusive, a patient‑specific series based on occupational or personal exposures can be added. This method pinpoints the exact trigger, allowing targeted avoidance.
Dermatoscopy provides a quick, bedside view of vascular patterns, scaling, and pigment distribution, helping differentiate eczematous lesions from early psoriasis. High‑frequency ultrasound (≥20 MHz) measures epidermal thickness and detects dermal edema, offering quantitative data on inflammation severity. Reflectance confocal microscopy delivers cellular‑level images of the epidermis and superficial dermis, useful when a biopsy is not feasible. These modalities are integrated into Liv Hospital’s diagnostic pathway when standard history and patch testing do not yield a clear cause, ensuring a precise and personalized diagnosis.
Upon arrival, patients are paired with a multilingual interpreter who helps capture detailed exposure histories and symptom timelines. The dermatology team conducts a thorough visual examination, photographs lesions for baseline documentation, and performs necessary tests such as patch testing, skin biopsy, or imaging. All laboratory work is performed in Liv Hospital’s accredited facility, ensuring rapid results. After diagnosis, a personalized management plan is provided in the patient’s native language, and follow‑up visits are scheduled with options for tele‑medicine. The hospital also offers visa assistance, accommodation recommendations, and a dedicated international patient coordinator to streamline the entire experience.
The initial review, two weeks after treatment initiation, assesses acute response through clinical exam and patient diary. A mid‑term assessment at 6–8 weeks evaluates therapeutic efficacy using the CDSI scoring system and photographic comparison, allowing adjustments to topical or systemic therapy. For chronic or occupational cases, long‑term reviews occur every six months, focusing on prevention, re‑evaluation of patch test results if new exposures arise, and reinforcement of avoidance strategies. All appointments can be conducted in‑person or via tele‑medicine, and interpreter support remains available throughout.
First‑line therapy usually involves topical corticosteroids to reduce inflammation, combined with barrier repair creams to restore skin integrity. For patients who cannot use steroids, calcineurin inhibitors such as tacrolimus offer an alternative. Systemic options, including oral antihistamines, short courses of oral steroids, or newer immunomodulators, are reserved for extensive or refractory cases. Education is a critical component: patients receive detailed avoidance instructions, product substitution guides, and lifestyle advice. All treatment plans are documented in the patient’s native language and reinforced during follow‑up visits.
BlogDermatologyMay 22, 2026We explain what is cetirizine, a safe, effective antihistamine providing quick, long-lasting allergy relief...
BlogDermatologyMay 22, 2026We explain red spots on legs, from benign causes like insect bites to serious issues like venous insufficie...
BlogDermatologyMay 22, 2026Red splotches on skin can signal various issues from mild to serious. We provide clear info on causes, trea...
BlogDermatologyMay 22, 2026If you notice red patches on scalp, we offer insights on causes, symptoms, and effective treatments with co...
BlogDermatologyMay 22, 2026Find rash under breast pictures and learn how to treat intertrigo with proven methods. We support your jour...
BlogDermatologyMay 22, 2026We explain rash tiny bumps on hands, their triggers, and relief methods. Find expert advice on managing dys...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 42 01